Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

8.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Cancer Vaccines01:30

Cancer Vaccines

1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human neonatal MR1T cells have more diverse TCR repertoires but reduced bacterial recognition than adult MR1T cells.

Nature communications·2026
Same author

CXCR3 signaling promotes Delta One T cell recruitment and antitumor efficacy in colorectal cancer.

Journal for immunotherapy of cancer·2026
Same author

Regulatory T cells sabotage anti-tumor γδ T cells by creating IL-2-deficient environments.

The Journal of experimental medicine·2026
Same author

Adoptive γδ T cell therapy controls cytomegalovirus infection in preclinical transplantation models.

Nature communications·2026
Same author

Follow the "DOTs": Vδ1+ γδ T cells as effectors of cancer immunotherapy.

The Journal of experimental medicine·2026
Same author

Fibroblastic reticular cells direct the initiation of T cell responses via CD44.

Nature·2026

Related Experiment Video

Updated: Apr 30, 2026

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

7.2K

Cancer immunotherapy by γδ T cells.

Adrian Hayday1,2,3, Julie Dechanet-Merville4, Jamie Rossjohn5,6,7

  • 1Francis Crick Institute, London, UK.

Science (New York, N.Y.)
|October 3, 2024
PubMed
Summary

Cancer immunotherapy shows promise for treating cancers using T cells. Research into gamma delta (γδ) T cells offers new potential for broader cancer treatment and improved patient outcomes.

More Related Videos

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.8K
Expansion and Enrichment of Gamma-Delta γδ T Cells from Apheresed Human Product
11:51

Expansion and Enrichment of Gamma-Delta γδ T Cells from Apheresed Human Product

Published on: September 22, 2021

11.4K

Related Experiment Videos

Last Updated: Apr 30, 2026

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

7.2K
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.8K
Expansion and Enrichment of Gamma-Delta γδ T Cells from Apheresed Human Product
11:51

Expansion and Enrichment of Gamma-Delta γδ T Cells from Apheresed Human Product

Published on: September 22, 2021

11.4K

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • Cancer immunotherapy leverages the immune system's ability to recognize and eliminate cancer cells.
  • Alpha beta (αβ) T cell-based therapies have shown success in treating certain cancers like metastatic melanoma.
  • Current challenges include expanding treatment benefits to more patients, diverse cancer types, and reducing adverse events.

Purpose of the Study:

  • To explore the potential of gamma delta (γδ) T cells as a novel approach in cancer immunotherapy.
  • To highlight the unique biological characteristics of γδ T cells that bridge innate and adaptive immunity.
  • To address existing challenges in cancer immunotherapy by leveraging γδ T cell biology.

Main Methods:

  • Review of current research on γδ T cell biology and their role in immunity.
  • Analysis of ongoing clinical trials involving γδ T cell-based therapies, including adoptive cell therapy and agonist antibodies.
  • Discussion of the distinct recognition capabilities and functional traits of γδ T cells.

Main Results:

  • γδ T cells possess unique recognition capabilities and bridge innate and adaptive immunity.
  • Clinical trials using γδ T cells show promising results for cancer treatment.
  • Identifiable problems in current γδ T cell therapies require further research and refinement.

Conclusions:

  • γδ T cells offer distinct advantages for cancer immunotherapy, potentially addressing current limitations.
  • Further research into the biology of γδ T cells is crucial for guiding the development of more effective immunotherapies.
  • Tailoring immunotherapies based on the specific biology of γδ T cells can improve treatment efficacy and patient outcomes.